Edgewise Therapeutics, Inc.

NASDAQ:EWTX

15.24 (USD) • At close June 6, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Omzet 000002.252000000000000000
Kosten van de omzet 0-1.05900.5340.5250.5330.4480.4370.2410.0920.1650.1540.1270.0780.0640.0510.0790000
Brutowinst 01.0590-0.534-0.5251.719-0.448-0.437-0.241-0.092-0.165-0.154-0.127-0.078-0.064-0.051-0.0790000
Brutowinstmarge 000000.763000000000000000
Onderzoek- en ontwikkelingskosten 36.75737.32332.22230.227.22127.68423.78619.55919.87616.61213.89412.40211.1249.0889.887.8615.365.1393.2383.6392.967
Algemene en administratieve kosten 9.2029.178.217.4277.0596.1785.6665.785.8285.4674.3684.0893.7023.7343.1962.5991.4971.2050.4050.3180.281
Verkoop- en marketingkosten 00.1060-0.054-0.0520000000000000000
Verkoop-, algemene en administratieve kosten 9.2029.2768.217.3737.0076.1785.6665.785.8285.4674.3684.0893.7023.7343.1962.5991.4971.2050.4050.3180.281
Overige kosten 000000000000000000000
Bedrijfskosten 45.95946.59940.43237.57334.22833.86229.45225.33925.70422.07918.26216.49114.82612.82213.07610.466.8576.3443.6433.9573.248
Bedrijfsresultaat -45.959-45.54-40.432-38.107-34.753-33.862-29.452-25.339-25.704-22.079-18.262-16.491-14.826-12.822-13.076-10.46-6.857-6.344-3.643-3.957-3.248
Bedrijfsresultaat ratio 00000-15.036000000000000000
Totaal overige inkomsten en kosten netto 5.1615.8786.3036.616.2283.7193.7393.872.8662.6640.7640.4240.1660.1260.1270.1070.0420.0020.0010.0030.063
Inkomen voor belasting -40.798-39.662-34.129-31.497-28.525-30.143-25.713-21.469-22.838-19.415-17.498-16.067-14.66-12.696-12.949-10.353-6.815-6.342-3.642-3.954-3.185
Inkomen voor belasting ratio 00000-13.385000000000000000
Belastingkosten 0-0.482000.4823.604-0.4970.339-3.107-2.664-0.764-0.424-0.16642.8130000000
Nettowinst -40.798-39.662-34.129-31.497-28.525-30.143-25.713-21.469-19.731-16.751-16.734-15.643-14.494-12.696-12.949-10.353-6.815-6.342-3.642-3.954-3.185
Nettowinstmarge 00000-13.385000000000000000
WPA (Winst Per Aandeel) -0.43-0.42-0.36-0.34-0.33-0.47-0.41-0.34-0.31-0.26-0.32-0.32-0.29-0.26-0.26-0.21-4.37-0.31-0.18-0.19-0.16
Verwaterde WPA -0.43-0.42-0.36-0.34-0.33-0.47-0.41-0.34-0.31-0.26-0.32-0.32-0.29-0.26-0.26-0.21-4.37-0.31-0.18-0.19-0.16
EBITDA -45.959-47.095-39.83-37.627-34.28-33.379-29.003-24.915-25.509-21.991-18.162-16.394-14.699-12.744-13.012-10.409-6.778-6.294-3.593-3.912-3.208
EBITDA ratio 00000-14.822000000000000000